chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Abasia, Contusion, Fungal infection, Joint swelling, Nodule
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old female with no drug allergies and a history of hysterectomy in 1988 and hip replacement in 2004, who on 03-JAN-2011 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 669410/1382Z, expired date 19-JAN-2012). There was no concomitant medication."Sometime between 07-JAN-2011 and 09-JAN-2011" the patient developed a red streak and blotchy bruising. The bruises "had nodules in the center". The patient also had swallowing difficulty and was admitted to the hospital on 11-FEB-2011. She was in the Intensive Care Unit and isolated because of her low white blood count. Treatment given for the adverse event included TYLENOL with codeine. Lab diagnostics studies performed included CBC (result not provided), enzyme test (result not provided), C 43 count (result not provided) and protein test (result not provided). The patient's adverse events were considered to be disabling and immediately life-threatening. At the time of reporting, the patient had not recovered. It was also reported that the patient got thrush from "magic mouth wash" and the patient's face swelled up shortly after receiving a tetanus shot (manufacturer unknown). A lot check has been initiated. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain in extremity, Platelet count decreased, Rash, Red blood cell count decreased, Red blood cell sedimentation rate
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old female with no drug allergies and a history of hysterectomy in 1988 and hip replacement in 2004, who on 03-JAN-2011 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 669410/1382Z, expired date 19-JAN-2012). There was no concomitant medication."Sometime between 07-JAN-2011 and 09-JAN-2011" the patient developed a red streak and blotchy bruising. The bruises "had nodules in the center". The patient also had swallowing difficulty and was admitted to the hospital on 11-FEB-2011. She was in the Intensive Care Unit and isolated because of her low white blood count. Treatment given for the adverse event included TYLENOL with codeine. Lab diagnostics studies performed included CBC (result not provided), enzyme test (result not provided), C 43 count (result not provided) and protein test (result not provided). The patient's adverse events were considered to be disabling and immediately life-threatening. At the time of reporting, the patient had not recovered. It was also reported that the patient got thrush from "magic mouth wash" and the patient's face swelled up shortly after receiving a tetanus shot (manufacturer unknown). A lot check has been initiated. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Skin discolouration, White blood cell count decreased
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old female with no drug allergies and a history of hysterectomy in 1988 and hip replacement in 2004, who on 03-JAN-2011 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 669410/1382Z, expired date 19-JAN-2012). There was no concomitant medication."Sometime between 07-JAN-2011 and 09-JAN-2011" the patient developed a red streak and blotchy bruising. The bruises "had nodules in the center". The patient also had swallowing difficulty and was admitted to the hospital on 11-FEB-2011. She was in the Intensive Care Unit and isolated because of her low white blood count. Treatment given for the adverse event included TYLENOL with codeine. Lab diagnostics studies performed included CBC (result not provided), enzyme test (result not provided), C 43 count (result not provided) and protein test (result not provided). The patient's adverse events were considered to be disabling and immediately life-threatening. At the time of reporting, the patient had not recovered. It was also reported that the patient got thrush from "magic mouth wash" and the patient's face swelled up shortly after receiving a tetanus shot (manufacturer unknown). A lot check has been initiated. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Candidiasis, Contusion, Dysphagia, Erythema, Full blood count
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old female with no drug allergies and a history of hysterectomy in 1988 and hip replacement in 2004, who on 03-JAN-2011 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 669410/1382Z, expired date 19-JAN-2012). There was no concomitant medication."Sometime between 07-JAN-2011 and 09-JAN-2011" the patient developed a red streak and blotchy bruising. The bruises "had nodules in the center". The patient also had swallowing difficulty and was admitted to the hospital on 11-FEB-2011. She was in the Intensive Care Unit and isolated because of her low white blood count. Treatment given for the adverse event included TYLENOL with codeine. Lab diagnostics studies performed included CBC (result not provided), enzyme test (result not provided), C 43 count (result not provided) and protein test (result not provided). The patient's adverse events were considered to be disabling and immediately life-threatening. At the time of reporting, the patient had not recovered. It was also reported that the patient got thrush from "magic mouth wash" and the patient's face swelled up shortly after receiving a tetanus shot (manufacturer unknown). A lot check has been initiated. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Intensive care, Laboratory test, Nodule, Patient isolation, Protein total
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old female with no drug allergies and a history of hysterectomy in 1988 and hip replacement in 2004, who on 03-JAN-2011 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 669410/1382Z, expired date 19-JAN-2012). There was no concomitant medication."Sometime between 07-JAN-2011 and 09-JAN-2011" the patient developed a red streak and blotchy bruising. The bruises "had nodules in the center". The patient also had swallowing difficulty and was admitted to the hospital on 11-FEB-2011. She was in the Intensive Care Unit and isolated because of her low white blood count. Treatment given for the adverse event included TYLENOL with codeine. Lab diagnostics studies performed included CBC (result not provided), enzyme test (result not provided), C 43 count (result not provided) and protein test (result not provided). The patient's adverse events were considered to be disabling and immediately life-threatening. At the time of reporting, the patient had not recovered. It was also reported that the patient got thrush from "magic mouth wash" and the patient's face swelled up shortly after receiving a tetanus shot (manufacturer unknown). A lot check has been initiated. Additional information has been requested.
Age: 67.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Rash macular, Swelling face, White blood cell count decreased
Clinical narrative: Information has been received from a registered nurse concerning a 67 year old female with no drug allergies and a history of hysterectomy in 1988 and hip replacement in 2004, who on 03-JAN-2011 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 669410/1382Z, expired date 19-JAN-2012). There was no concomitant medication."Sometime between 07-JAN-2011 and 09-JAN-2011" the patient developed a red streak and blotchy bruising. The bruises "had nodules in the center". The patient also had swallowing difficulty and was admitted to the hospital on 11-FEB-2011. She was in the Intensive Care Unit and isolated because of her low white blood count. Treatment given for the adverse event included TYLENOL with codeine. Lab diagnostics studies performed included CBC (result not provided), enzyme test (result not provided), C 43 count (result not provided) and protein test (result not provided). The patient's adverse events were considered to be disabling and immediately life-threatening. At the time of reporting, the patient had not recovered. It was also reported that the patient got thrush from "magic mouth wash" and the patient's face swelled up shortly after receiving a tetanus shot (manufacturer unknown). A lot check has been initiated. Additional information has been requested.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, SMALL, TYP, ANTH, HEPAB, SMALL, TYP, ANTH, HEPAB, SMALL, TYP
Symptoms: Cellulitis, Injection site vesicles, Tattoo
Clinical narrative: Multiple pustular lesions around SPV site. Rash, oth nonspecific skin eruption.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, SMALL, TYP, ANTH, HEPAB, SMALL, TYP, ANTH, HEPAB, SMALL, TYP
Symptoms: Injection site pustule, Injection site rash, Rash pustular
Clinical narrative: Multiple pustular lesions around SPV site. Rash, oth nonspecific skin eruption.
Age: 19.0
Sex: M
Vaccine: ANTH, HEPAB, SMALL, TYP, ANTH, HEPAB, SMALL, TYP, ANTH, HEPAB, SMALL, TYP
Symptoms: Blister, Cellulitis, Injection site vesicles
Clinical narrative: Multiple pustular lesions around SPV site. Rash, oth nonspecific skin eruption.
Age: 17.0
Sex: F
Vaccine: MNQ, VARCEL, VARCEL
Symptoms: Neonatal disorder, Premature labour
Clinical narrative: Follow-up information was received from medical records for VARIVAX, a Pregnancy Registry product, concerning a 17 year old G1P0 female non-smoker, non-drinker, negative family history for birth defects, with eczema and a history of premenstrual dysphoric disorder and left wrist fracture (2000). On 31-JAN-2011, the 17 year old female with IDDM was admitted with contractions and uncontrolled hyperglycemia. She was treated with intravenous fluids, subcutaneous terbutaline, and oral PROCARDIA with no resolution of the contractions. She was subsequently treated with magnesium and ampicillin. Pregnancy complications included inadvertent first trimester vaccination with varicella and meningococcal vaccines. The mother was Rhesus negative for which she needed RHOGAM. On 03-FEB-2011, she delivered vaginally a 1560 gram, 41 cm male with Apgars of 8 and 9. The baby was admitted to the NICU for observation based on indications of prematurity and respiratory distress. Labor complications included magnesium toxicity. Assessment: gestational age 30 + 4 weeks, hypovolemia, poor perfusion with capillary refill approx 5 seconds after delivery, venous blood gases with -3 base deficit. The baby was pale pink in color in room air. He had minimal retractions and breath sounds equal with air exchange slightly decreased. No dysmorphic features were present. There was facial and neck bruising with edema noted on the right side of his neck, and there was moderate cranial molding. Ears were normal, no preauricular tags or pits. The baby was positive for respiratory distress with minimal retractions and positive bilateral equal air entry. S1 and S2 were audible, and there was no murmur. Femoral pulses were palpable bilaterally. The baby had pre-term male genitalia. Extremities had full range of motion with no hip clicks. His back was straight and there was no dimple. Neurologically, tone was appropriate for gestational age. Upon internal review, the adverse event of premature baby was determined to be an Other Important Medical Event. All available medical records will be provided upon request. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: MNQ, VARCEL, VARCEL
Symptoms: Delivery, Drug exposure during pregnancy, Drug toxicity, Hyperglycaemia, Rhesus antibodies negative
Clinical narrative: Follow-up information was received from medical records for VARIVAX, a Pregnancy Registry product, concerning a 17 year old G1P0 female non-smoker, non-drinker, negative family history for birth defects, with eczema and a history of premenstrual dysphoric disorder and left wrist fracture (2000). On 31-JAN-2011, the 17 year old female with IDDM was admitted with contractions and uncontrolled hyperglycemia. She was treated with intravenous fluids, subcutaneous terbutaline, and oral PROCARDIA with no resolution of the contractions. She was subsequently treated with magnesium and ampicillin. Pregnancy complications included inadvertent first trimester vaccination with varicella and meningococcal vaccines. The mother was Rhesus negative for which she needed RHOGAM. On 03-FEB-2011, she delivered vaginally a 1560 gram, 41 cm male with Apgars of 8 and 9. The baby was admitted to the NICU for observation based on indications of prematurity and respiratory distress. Labor complications included magnesium toxicity. Assessment: gestational age 30 + 4 weeks, hypovolemia, poor perfusion with capillary refill approx 5 seconds after delivery, venous blood gases with -3 base deficit. The baby was pale pink in color in room air. He had minimal retractions and breath sounds equal with air exchange slightly decreased. No dysmorphic features were present. There was facial and neck bruising with edema noted on the right side of his neck, and there was moderate cranial molding. Ears were normal, no preauricular tags or pits. The baby was positive for respiratory distress with minimal retractions and positive bilateral equal air entry. S1 and S2 were audible, and there was no murmur. Femoral pulses were palpable bilaterally. The baby had pre-term male genitalia. Extremities had full range of motion with no hip clicks. His back was straight and there was no dimple. Neurologically, tone was appropriate for gestational age. Upon internal review, the adverse event of premature baby was determined to be an Other Important Medical Event. All available medical records will be provided upon request. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: MNQ, VARCEL, VARCEL
Symptoms: Uterine contractions during pregnancy
Clinical narrative: Follow-up information was received from medical records for VARIVAX, a Pregnancy Registry product, concerning a 17 year old G1P0 female non-smoker, non-drinker, negative family history for birth defects, with eczema and a history of premenstrual dysphoric disorder and left wrist fracture (2000). On 31-JAN-2011, the 17 year old female with IDDM was admitted with contractions and uncontrolled hyperglycemia. She was treated with intravenous fluids, subcutaneous terbutaline, and oral PROCARDIA with no resolution of the contractions. She was subsequently treated with magnesium and ampicillin. Pregnancy complications included inadvertent first trimester vaccination with varicella and meningococcal vaccines. The mother was Rhesus negative for which she needed RHOGAM. On 03-FEB-2011, she delivered vaginally a 1560 gram, 41 cm male with Apgars of 8 and 9. The baby was admitted to the NICU for observation based on indications of prematurity and respiratory distress. Labor complications included magnesium toxicity. Assessment: gestational age 30 + 4 weeks, hypovolemia, poor perfusion with capillary refill approx 5 seconds after delivery, venous blood gases with -3 base deficit. The baby was pale pink in color in room air. He had minimal retractions and breath sounds equal with air exchange slightly decreased. No dysmorphic features were present. There was facial and neck bruising with edema noted on the right side of his neck, and there was moderate cranial molding. Ears were normal, no preauricular tags or pits. The baby was positive for respiratory distress with minimal retractions and positive bilateral equal air entry. S1 and S2 were audible, and there was no murmur. Femoral pulses were palpable bilaterally. The baby had pre-term male genitalia. Extremities had full range of motion with no hip clicks. His back was straight and there was no dimple. Neurologically, tone was appropriate for gestational age. Upon internal review, the adverse event of premature baby was determined to be an Other Important Medical Event. All available medical records will be provided upon request. Additional information has been requested.
Age: 0.38
Sex: M
Vaccine: PNC13, RV5
Symptoms: Crying, Irritability
Clinical narrative: Really fussy last night. Cried intensely 10-15 minutes. Last time he cried for 2 hours, today he was back to normal.
Age: 72.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Nerve injury
Clinical narrative: Shot was very painful. Has been in pain since she had it. Shooting pain at times esp at nite. Has been to the doctor. Said it irritated the nerves & will take a while to heal - pain.
Age: 24.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Dyspnoea, Throat tightness, Wheezing
Clinical narrative: Tdap administered at client's workplace during health dept. onsite clinic.  Client reported ED visit on 2/12/11 d/t complaints of shortness of breath, wheezing, & sensation of "throat closing".  Drove self to ED where she received oral prednisone treatment.  Also given prednisone 20 mg tablets #4 to self-administer 1 tab po BID x 2 d.  States symptoms resolved 2/14/11 without further medical care/eval.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Joint range of motion decreased, Limb discomfort, Muscular weakness, Pain in extremity
Clinical narrative: Employee reports that following the vaccination, her left upper arm exhibited more soreness than she usually notices following a flu vaccination.  In subsequent days, she noted weakness to her left arm and pain.  She has developed subsequent decreased range of motion to the left shoulder/uppper arm with ongoing discomfort localized to the left upper arm.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: X-ray normal
Clinical narrative: Employee reports that following the vaccination, her left upper arm exhibited more soreness than she usually notices following a flu vaccination.  In subsequent days, she noted weakness to her left arm and pain.  She has developed subsequent decreased range of motion to the left shoulder/uppper arm with ongoing discomfort localized to the left upper arm.
Age: 40.0
Sex: M
Vaccine: FLU3
Symptoms: Feeling hot, Generalised erythema, Pruritus, Rash, Swelling
Clinical narrative: PATIENT PRESENTED WITH GENERALIZED REDNESS WITH RED SWELLINGS IN NECK, BODY, FACE AND BOTH UPPER LIMBS. PATIENT REFERS RASH AND ITCH IN THE BODY AND FELT HOT. THEY PROCEDED TO INJECT EPIPEN (EPINEPHRINE) IN THE RIGHT TIGH BUT THE PATIENT CONTINUED WITH THE REDNESS AND RASH (15 MINUTES LATER). HE WAS TAKEN TO THE EMERGENCY ROOM (HOSPITAL).
Age: 33.0
Sex: F
Vaccine: DTAP
Symptoms: Cough, Erythema, Headache, Local swelling, Rash
Clinical narrative: States she had local swelling initially, then noticed redness and rash on 2/21 in the afernoon. Also noticed ras on anterior abdomen and started with dry cough on 2/22/11. Did state she had a headache following the vaccine.
Age: 32.0
Sex: F
Vaccine: FLU3, FLUX, TDAP
Symptoms: Complication of pregnancy, Drug exposure during pregnancy, Hypertension, Oedema peripheral, Premature separation of placenta
Clinical narrative: Initial report received from the patient's spouse on 02 November 2010. A pregnant female patient (date of birth not reported) had received a first dose of ADACEL (lot number not reported) on 23 October 2010. The patient's estimated date of delivery is 09 December 2010. At the time of this report, the patient had not experienced any adverse events since being vaccinated with ADACEL. Follow-up information received from the patient's spouse on 14 and 18 February 2011. Upon receipt of this information, it was determined this case meets seriousness criteria and has been upgraded to serious. The patient was reported as being 34 years of age; however by calculation from the patient's date of birth the patient was 32 years of age at the time of vaccination. Confirmation of the patient's date of birth has been requested. The patient had received the ADACEL vaccination at "11:00 pm" on 23 October 2010. She had also received a flu shot in October 2010 of which the trade name, manufacturer name, lot number, route and site of administration were not reported. The patient had no reported medical history, no maternal drug use, and no infertility treatments. Obstetrical history included no prior pregnancies. The date of the patient's last menstrual period was 01 March 2010 with expected date of delivery 04 December 2010. Current pregnancy history included high blood pressure (reading not provided) and swelling of face and legs with no dates of onset. Per the spouse, the patient was followed by a mid-wife and experienced pregnancy complication on 04 December 2010 when she presented with "placenta rupture and detachment" that resulted in emergency cesarean section and delivery of a single 6 pound healthy male baby. It was reported that the baby is healthy and fine and the baby had no congenital anomalies. Hospitalization was not mentioned. No other medical information was provided. At the time of this report, the patient had recovered. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: FLU3, FLUX, TDAP
Symptoms: Swelling face
Clinical narrative: Initial report received from the patient's spouse on 02 November 2010. A pregnant female patient (date of birth not reported) had received a first dose of ADACEL (lot number not reported) on 23 October 2010. The patient's estimated date of delivery is 09 December 2010. At the time of this report, the patient had not experienced any adverse events since being vaccinated with ADACEL. Follow-up information received from the patient's spouse on 14 and 18 February 2011. Upon receipt of this information, it was determined this case meets seriousness criteria and has been upgraded to serious. The patient was reported as being 34 years of age; however by calculation from the patient's date of birth the patient was 32 years of age at the time of vaccination. Confirmation of the patient's date of birth has been requested. The patient had received the ADACEL vaccination at "11:00 pm" on 23 October 2010. She had also received a flu shot in October 2010 of which the trade name, manufacturer name, lot number, route and site of administration were not reported. The patient had no reported medical history, no maternal drug use, and no infertility treatments. Obstetrical history included no prior pregnancies. The date of the patient's last menstrual period was 01 March 2010 with expected date of delivery 04 December 2010. Current pregnancy history included high blood pressure (reading not provided) and swelling of face and legs with no dates of onset. Per the spouse, the patient was followed by a mid-wife and experienced pregnancy complication on 04 December 2010 when she presented with "placenta rupture and detachment" that resulted in emergency cesarean section and delivery of a single 6 pound healthy male baby. It was reported that the baby is healthy and fine and the baby had no congenital anomalies. Hospitalization was not mentioned. No other medical information was provided. At the time of this report, the patient had recovered. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: FLU3, FLUX, TDAP
Symptoms: Caesarean section, Complication of pregnancy, Drug exposure during pregnancy, Hypertension, Normal newborn
Clinical narrative: Initial report received from the patient's spouse on 02 November 2010. A pregnant female patient (date of birth not reported) had received a first dose of ADACEL (lot number not reported) on 23 October 2010. The patient's estimated date of delivery is 09 December 2010. At the time of this report, the patient had not experienced any adverse events since being vaccinated with ADACEL. Follow-up information received from the patient's spouse on 14 and 18 February 2011. Upon receipt of this information, it was determined this case meets seriousness criteria and has been upgraded to serious. The patient was reported as being 34 years of age; however by calculation from the patient's date of birth the patient was 32 years of age at the time of vaccination. Confirmation of the patient's date of birth has been requested. The patient had received the ADACEL vaccination at "11:00 pm" on 23 October 2010. She had also received a flu shot in October 2010 of which the trade name, manufacturer name, lot number, route and site of administration were not reported. The patient had no reported medical history, no maternal drug use, and no infertility treatments. Obstetrical history included no prior pregnancies. The date of the patient's last menstrual period was 01 March 2010 with expected date of delivery 04 December 2010. Current pregnancy history included high blood pressure (reading not provided) and swelling of face and legs with no dates of onset. Per the spouse, the patient was followed by a mid-wife and experienced pregnancy complication on 04 December 2010 when she presented with "placenta rupture and detachment" that resulted in emergency cesarean section and delivery of a single 6 pound healthy male baby. It was reported that the baby is healthy and fine and the baby had no congenital anomalies. Hospitalization was not mentioned. No other medical information was provided. At the time of this report, the patient had recovered. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: FLU3, FLUX, TDAP
Symptoms: Oedema peripheral, Placental disorder, Premature separation of placenta, Swelling face
Clinical narrative: Initial report received from the patient's spouse on 02 November 2010. A pregnant female patient (date of birth not reported) had received a first dose of ADACEL (lot number not reported) on 23 October 2010. The patient's estimated date of delivery is 09 December 2010. At the time of this report, the patient had not experienced any adverse events since being vaccinated with ADACEL. Follow-up information received from the patient's spouse on 14 and 18 February 2011. Upon receipt of this information, it was determined this case meets seriousness criteria and has been upgraded to serious. The patient was reported as being 34 years of age; however by calculation from the patient's date of birth the patient was 32 years of age at the time of vaccination. Confirmation of the patient's date of birth has been requested. The patient had received the ADACEL vaccination at "11:00 pm" on 23 October 2010. She had also received a flu shot in October 2010 of which the trade name, manufacturer name, lot number, route and site of administration were not reported. The patient had no reported medical history, no maternal drug use, and no infertility treatments. Obstetrical history included no prior pregnancies. The date of the patient's last menstrual period was 01 March 2010 with expected date of delivery 04 December 2010. Current pregnancy history included high blood pressure (reading not provided) and swelling of face and legs with no dates of onset. Per the spouse, the patient was followed by a mid-wife and experienced pregnancy complication on 04 December 2010 when she presented with "placenta rupture and detachment" that resulted in emergency cesarean section and delivery of a single 6 pound healthy male baby. It was reported that the baby is healthy and fine and the baby had no congenital anomalies. Hospitalization was not mentioned. No other medical information was provided. At the time of this report, the patient had recovered. Documents held by sender: None.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Gait disturbance, Guillain-Barre syndrome
Clinical narrative: GUILLAIN-BARRE Syndrome - difficulty walking.
Age: 75.0
Sex: F
Vaccine: FLU(H1N1), FLUX
Symptoms: Culture urine, Diplegia, Paralysis
Clinical narrative: Paralysis of arms, hands and legs.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Axillary pain, Mobility decreased, Musculoskeletal pain
Clinical narrative: Pt reports severe pain radiating thru shoulder & armpit for approximately 48 hrs post-vaccine - so much that she could hardly move her arm around. Treated w/ibuprofen at home - she said it barely helped.
Age: 14.0
Sex: F
Vaccine: FLU3
Symptoms: Loss of consciousness
Clinical narrative: After about 5 minutes patient started to black out after 5 minutes of receiving the flu shot. The event happened on 01/31/11 approximately at 7:30 pm. Pt started to recover about 5 minutes later.
Age: 1.01
Sex: F
Vaccine: HEPA, MMRV, PNC13
Symptoms: Rash generalised
Clinical narrative: Rash, generalized 10 days after MMRV #1.
Age: 44.0
Sex: F
Vaccine: TYP
Symptoms: Activities of daily living impaired, Fatigue, Feeling hot, Malaise, Pyrexia
Clinical narrative: Pt called on 2-17-11 to report a reaction to Typhoid vaccine. She c/o hives, fever and fatigue. On Monday Feb 14 she received TWINRIX #1, TDAP and a prescription for oral Typhoid vaccine. On Tuesday she states she had some fatigue and arms were tender to pressure. No fever was noted on Tuesday. She finished the amoxicillin on Tuesday from a previous sinus infection. On Wednesday morning approx 8:00 she took the first oral Typhoid pill. Within 30 minutes she had a hot feeling in her cheeks and hives started on face and neck. Rash eventually spread to palms of hands. She took ADVIL at approx 2:00 p.m. for the hot feeling. On Wednesday eve, her temperature was 99.1 and she took more ADVIL. No anti-allergy medicine was taken. On Thursday am the rash was gone and she had a fever of 99.4 and c/o fatigue and malaise. She stayed home from work. She took ADVIL 2 times on Thursday. On Friday am, Feb 18, her temperature is 99.0. Cheeks are warm but no rash is present. She took ADVIL this morning. I advised her to stop taking the oral Typhoid vaccine. I will discuss with Dr. whether to give Typhoid injectable vaccine and or #2 TWINRIX. VAERS report was started.
Age: 44.0
Sex: F
Vaccine: TYP
Symptoms: Rash, Skin warm, Tenderness, Urticaria
Clinical narrative: Pt called on 2-17-11 to report a reaction to Typhoid vaccine. She c/o hives, fever and fatigue. On Monday Feb 14 she received TWINRIX #1, TDAP and a prescription for oral Typhoid vaccine. On Tuesday she states she had some fatigue and arms were tender to pressure. No fever was noted on Tuesday. She finished the amoxicillin on Tuesday from a previous sinus infection. On Wednesday morning approx 8:00 she took the first oral Typhoid pill. Within 30 minutes she had a hot feeling in her cheeks and hives started on face and neck. Rash eventually spread to palms of hands. She took ADVIL at approx 2:00 p.m. for the hot feeling. On Wednesday eve, her temperature was 99.1 and she took more ADVIL. No anti-allergy medicine was taken. On Thursday am the rash was gone and she had a fever of 99.4 and c/o fatigue and malaise. She stayed home from work. She took ADVIL 2 times on Thursday. On Friday am, Feb 18, her temperature is 99.0. Cheeks are warm but no rash is present. She took ADVIL this morning. I advised her to stop taking the oral Typhoid vaccine. I will discuss with Dr. whether to give Typhoid injectable vaccine and or #2 TWINRIX. VAERS report was started.
Age: 1.25
Sex: F
Vaccine: VARCEL
Symptoms: Injection site reaction, Varicella
Clinical narrative: Mild case of varicella at injection site
Age: 46.0
Sex: M
Vaccine: ANTH
Symptoms: Blood pressure abnormal
Clinical narrative: Prior to vaccine being given my blood pressure was 120/80, when they checked it again to give my second dose it was 170/101, I was then given a 5 day hypertension evaluation and put on blood pressure medicine and given the 2nd shot. I received my 3rd AVA abroad and 3 days later my BP was 90/60. At that point they told me to stop taking any blood pressure meds.  Now my BP is unstable and I am back to taking Zestoretic and due for my 4th AVA. The doctor at the site says this is a very common occurence and I shouldn't worry about it. I happen to think that doctor needs retraining.
Age: 0.18
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Injection site erythema, Injection site induration, Local reaction
Clinical narrative: Mild -> moderate local reaction to (RT) thigh, app. 2cm x 1cm area with erythema & firm induration. 2mo imm. given on 2/21/11, s/s appeared 2/23/11 Tx - apply warm/moist compresses x 10-15 min, PRN.
Age: 33.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Cellulitis, White blood cell count increased
Clinical narrative: Cellulitis like reaction developed over 24-96 hrs post injection.
Age: 33.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Injection site erythema, Injection site swelling, Nausea, Pyrexia, White blood cell count increased
Clinical narrative: Cellulitis like reaction developed over 24-96 hrs post injection.
Age: 14.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Syncope
Clinical narrative: Client had syncopal event after the administration of GARDASIL (HPV) vaccine. Client issue was resolved almost immediately. Client was instructed to lay down to rest and given cool washcloth to apply to forehead as needed and water to drink until he felt good enough to leave.
Age: 16.0
Sex: F
Vaccine: TDAP
Symptoms: Chlamydia test positive, Dizziness, Feeling hot, Pulse pressure decreased
Clinical narrative: (2pm) A few minutes after injection, patient complained of feeling dizzy & hot. She was helped to a chair, drank some Coke-cola, still felt dizzy & helped to lie down. She then felt better, drank more cola. After eating soup & juice she felt better. (240PM) BP at 2 PM 64/50; pulse - weak BP at 240PM 115/68 pulse 80.
Age: 0.36
Sex: F
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Abnormal faeces, Diarrhoea, Flatulence, Irritability, Stool analysis
Clinical narrative: Loose stools 24 hour after ROTATEQ. Foul liquid stool x 48 hours gassy & irritable x 8 days.
Age: 13.0
Sex: F
Vaccine: FLU3
Symptoms: Ear pain, Speech disorder, VIIth nerve paralysis
Clinical narrative: Patient presented to clinic on 12/28/10 with a 10-day history of left ear pain and left-side facial droop. Stated that it was sometimes difficult to talk. Patient had no other illnesses at this time.
Age: 21.0
Sex: M
Vaccine: FLU3, TDAP
Symptoms: Dysgeusia, Hypoaesthesia facial, VIIth nerve paralysis
Clinical narrative: Patient presented to clinic on 11/19/10 with a 3-day history of left-side facial numbness and drooping as well as trouble tasting food.
Age: 12.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Pruritus
Clinical narrative: Red patch 10cm x 10cm Rt deltoid. Itching but no induration or swelling. Afebrile.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, VIIth nerve paralysis
Clinical narrative: Patient presented to ER with left facial droop, neck numbness. It was noted in the triage note that this "happened earlier today and in the past."
Age: 4.0
Sex: M
Vaccine: DTAPIPV, PNC13
Symptoms: Injection site erythema, Injection site swelling, Pain
Clinical narrative: Patient c/o of pain to his mother about 9:30am. Mom noted area (about the size of her palm) to bil legs red and swollen. Informed mom to apply cool compresses and apply Myoflex Cream to area q 3-4 hours. Give Ibuprofen or Benadryl for pain and/or inflammation.
Age: 27.0
Sex: M
Vaccine: FLU3
Symptoms: Eye pruritus, Hypoaesthesia oral, Lacrimation increased, Swelling face, VIIth nerve paralysis
Clinical narrative: "I think I'm having an allergic reation"  Pt c/o tongue going numb last night but states he's getting feeling back into it now. States right side of face is swollen and drooping, and bil eye watering and itching.  Pt states no new foods, meds or substances withing the past 24 hours
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Rash
Clinical narrative: 101 fever for 24 hours, red rash on hands, face, tummy, and back was given Benadryl.
Age: 44.0
Sex: M
Vaccine: ANTH
Symptoms: Unevaluable event
Clinical narrative: No details available at this time.  Reaction attributed to Anthrax shot #1 by Emergency Room Physician
Age: 1.33
Sex: F
Vaccine: FLU3, HEPA, VARCEL, FLU3, HEPA, VARCEL
Symptoms: Convulsion, Pyrexia
Clinical narrative: Pt. developed high fever and convulsions(seizures)repeatedly. she was transported from 911 to regional hospital where they transported her to medical park where she was admitted.
Age: 1.33
Sex: F
Vaccine: FLU3, HEPA, VARCEL, FLU3, HEPA, VARCEL
Symptoms: Convulsion, Dyskinesia, Dyspnoea, Gaze palsy, Immediate post-injection reaction
Clinical narrative: Pt. developed high fever and convulsions(seizures)repeatedly. she was transported from 911 to regional hospital where they transported her to medical park where she was admitted.
Age: 1.33
Sex: F
Vaccine: FLU3, HEPA, VARCEL, FLU3, HEPA, VARCEL
Symptoms: Pyrexia
Clinical narrative: Pt. developed high fever and convulsions(seizures)repeatedly. she was transported from 911 to regional hospital where they transported her to medical park where she was admitted.
Age: 23.0
Sex: M
Vaccine: SMALL
Symptoms: Rash erythematous, Rash generalised, Tenderness
Clinical narrative: Tender Generalized Erythematous Rash, no pustule formation.
Age: 87.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza
Clinical narrative: Initial report received from a health care professional on 09 Feb 2011: This patient received FLUVIRIN (batch number not reported) 0.5 ml, intramuscularly on Oct 2010. The patient was admitted to hospital and diagnosed with swine flu on 08 Feb 2011. No other information was provided at the time of this report.
Age: 0.17
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Haematochezia, Mucous stools, Occult blood negative
Clinical narrative: small amt of blood and mucous in stool
Age: 6.0
Sex: F
Vaccine: PPV
Symptoms: Abasia, Pain, Pyrexia, Rash erythematous, Weight bearing difficulty
Clinical narrative: On 01/12/2011 she developed a high fever (102.7) that lasted most of the day. She was also unable to put any weight on the leg that the vaccine was administered in. By early evening (around 1800) she developed a flat, irregular red rash at the top of her right thigh (the vaccine was administered in the side of the right thigh). The red spot was exceptionally painful. Nothing could touch it - clothing, a person, etc. She was unable to walk for two full days. She had the painful red spot for three days. It began to diminish on the fourth day and was fully resolved after five days. The spot was about 2 inches long and about an inch or so across.
Age: 89.0
Sex: F
Vaccine: TD
Symptoms: Asthenia, Dysphagia, Muscle spasms
Clinical narrative: Pt. suffered a fall about 2 weeks ago and had abrasion and received tetanus vaccine and about 48 hours post vaccination she became extremely weak with dysphagia and increased muscle spasm.
Age: 41.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Back pain, Gait disturbance, Joint stiffness, Musculoskeletal stiffness
Clinical narrative: Received call from patient 2-17-11 at 10:30AM stating that she has "pain & stiffness at her wrist, thighs, hips, & lower back". "I walk like a marionette". Denies fever, nausea and/or rash. No shortness of breath. Pt states that symptoms started 4 days after receiving MMR vaccine. "Walking better today but still painful".
Age: 41.0
Sex: F
Vaccine: MMR
Symptoms: Pain in extremity
Clinical narrative: Received call from patient 2-17-11 at 10:30AM stating that she has "pain & stiffness at her wrist, thighs, hips, & lower back". "I walk like a marionette". Denies fever, nausea and/or rash. No shortness of breath. Pt states that symptoms started 4 days after receiving MMR vaccine. "Walking better today but still painful".
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Convulsion, Influenza like illness, Malaise
Clinical narrative: The patient received the Flu vaccine on 10/12/2010. On 02/22/2011 the patient reported that she had been experiencing more frequent seizure events, and been sick like having a flu after the flu shot.
Age: 41.0
Sex: M
Vaccine: TYP
Symptoms: Activities of daily living impaired, Arthralgia, Back pain, Bronchitis, Cough
Clinical narrative: Requested consult for evaluation of diffuse myalgia, arthralgia and URI like symptoms following receipt of several influenza and anthrax vaccinations. He received his Influenza vaccinations on 3/2/2003, 12/30/2004, 11/26/2007, H1N1 on 2/19/2010, and FLUMIST on 10/16/2010. Approximately 5-8 hours following each of these vaccinations (with and without other vaccines administered) he complained of feeling diffuse body aches, headaches, and nasal congestion that would last 3-4 days. Headaches and nasal congestion were worse with 2010 FLUMIST. He self-treated with TYLENOL, ADVIL and/or OTC cold medications and advised he was treated for UTI in 2010. He remembers being out of work 3 days each time. He received his Anthrax vaccinations 6/27/2007, 8/24/2007, and 3/1/2008 with sequential worsening of diffuse myalgia and arthralgia to knees/hands, nasal congestion, fatigue and frontal headaches. He recalls onset of symptoms was about 1-2 hours post vaccination (each vac.). He remembers duration of all symptoms in 2007 was 2-3 days and 5-7 days in 2008 before fully resolving. He treated with MOTRIN and increased fluid intake. However, a review of available medical records documented an exam on 7/14/2007 for complaints of a sore throat, cough, bilateral ear pressure, and congestion beginning 6/29/2007 unrelieved with OTC medications (onset 2 days after AVA vac#1 versus above recall of 1-2 hours post vaccination). His exam noted enlarged erythematous swollen tonsils with exudate, mucoid nasal discharge, and expiratory wheezing that cleared with cough. He was diagnosed with bronchitis and treated with Z-PAK, albuterol inhaler, ENTEX PSE, and TYLENOL. There were no throat cultures obtained. He reported full recovery over next few weeks. On 4/7/2008, while deployed, he was examined for complaints of 2 week history of headaches, stuffed ears, sore throat, cough, sinus & chest congestion (symptom onset at 3/23/08 or 22 days after AVA vac #3). His exam was unremarkable with some clear nasal discharge and erythema cobblestone appearance to oral cavity. He was diagnosed and treated for sinusitis and URI with full recovery. Agency form on 8/15/2008 was marked yes for complaints of painful joints, back pain, heartburn and increased irritability. X-rays in Sept-Oct 2009 showed degenerative disc disease to L5-S1 and mild vacuum phenomena with spurring L5; and, DDD to C5-6 and C6-7 with straightening of cervical curvature. As of 2011 his diagnoses include hypertension, hypercholesterolemia, glucose intolerance, and he sees a chiropractor for episodic cervical, thoracic and lumbar spine somatic dysfunction (pain). He is currently preparing for a June 2011 deployment, is in smoking cessation program, voices no restrictions in daily activities, or an increase in seasonal URI like events pre-post vaccinations.
Age: 41.0
Sex: M
Vaccine: TYP
Symptoms: Dyspepsia, Ear discomfort, Ex-tobacco user, Fatigue, Glucose tolerance impaired
Clinical narrative: Requested consult for evaluation of diffuse myalgia, arthralgia and URI like symptoms following receipt of several influenza and anthrax vaccinations. He received his Influenza vaccinations on 3/2/2003, 12/30/2004, 11/26/2007, H1N1 on 2/19/2010, and FLUMIST on 10/16/2010. Approximately 5-8 hours following each of these vaccinations (with and without other vaccines administered) he complained of feeling diffuse body aches, headaches, and nasal congestion that would last 3-4 days. Headaches and nasal congestion were worse with 2010 FLUMIST. He self-treated with TYLENOL, ADVIL and/or OTC cold medications and advised he was treated for UTI in 2010. He remembers being out of work 3 days each time. He received his Anthrax vaccinations 6/27/2007, 8/24/2007, and 3/1/2008 with sequential worsening of diffuse myalgia and arthralgia to knees/hands, nasal congestion, fatigue and frontal headaches. He recalls onset of symptoms was about 1-2 hours post vaccination (each vac.). He remembers duration of all symptoms in 2007 was 2-3 days and 5-7 days in 2008 before fully resolving. He treated with MOTRIN and increased fluid intake. However, a review of available medical records documented an exam on 7/14/2007 for complaints of a sore throat, cough, bilateral ear pressure, and congestion beginning 6/29/2007 unrelieved with OTC medications (onset 2 days after AVA vac#1 versus above recall of 1-2 hours post vaccination). His exam noted enlarged erythematous swollen tonsils with exudate, mucoid nasal discharge, and expiratory wheezing that cleared with cough. He was diagnosed with bronchitis and treated with Z-PAK, albuterol inhaler, ENTEX PSE, and TYLENOL. There were no throat cultures obtained. He reported full recovery over next few weeks. On 4/7/2008, while deployed, he was examined for complaints of 2 week history of headaches, stuffed ears, sore throat, cough, sinus & chest congestion (symptom onset at 3/23/08 or 22 days after AVA vac #3). His exam was unremarkable with some clear nasal discharge and erythema cobblestone appearance to oral cavity. He was diagnosed and treated for sinusitis and URI with full recovery. Agency form on 8/15/2008 was marked yes for complaints of painful joints, back pain, heartburn and increased irritability. X-rays in Sept-Oct 2009 showed degenerative disc disease to L5-S1 and mild vacuum phenomena with spurring L5; and, DDD to C5-6 and C6-7 with straightening of cervical curvature. As of 2011 his diagnoses include hypertension, hypercholesterolemia, glucose intolerance, and he sees a chiropractor for episodic cervical, thoracic and lumbar spine somatic dysfunction (pain). He is currently preparing for a June 2011 deployment, is in smoking cessation program, voices no restrictions in daily activities, or an increase in seasonal URI like events pre-post vaccinations.
Age: 41.0
Sex: M
Vaccine: TYP
Symptoms: Headache, Hypercholesterolaemia, Hypertension, Intervertebral disc degeneration, Irritability
Clinical narrative: Requested consult for evaluation of diffuse myalgia, arthralgia and URI like symptoms following receipt of several influenza and anthrax vaccinations. He received his Influenza vaccinations on 3/2/2003, 12/30/2004, 11/26/2007, H1N1 on 2/19/2010, and FLUMIST on 10/16/2010. Approximately 5-8 hours following each of these vaccinations (with and without other vaccines administered) he complained of feeling diffuse body aches, headaches, and nasal congestion that would last 3-4 days. Headaches and nasal congestion were worse with 2010 FLUMIST. He self-treated with TYLENOL, ADVIL and/or OTC cold medications and advised he was treated for UTI in 2010. He remembers being out of work 3 days each time. He received his Anthrax vaccinations 6/27/2007, 8/24/2007, and 3/1/2008 with sequential worsening of diffuse myalgia and arthralgia to knees/hands, nasal congestion, fatigue and frontal headaches. He recalls onset of symptoms was about 1-2 hours post vaccination (each vac.). He remembers duration of all symptoms in 2007 was 2-3 days and 5-7 days in 2008 before fully resolving. He treated with MOTRIN and increased fluid intake. However, a review of available medical records documented an exam on 7/14/2007 for complaints of a sore throat, cough, bilateral ear pressure, and congestion beginning 6/29/2007 unrelieved with OTC medications (onset 2 days after AVA vac#1 versus above recall of 1-2 hours post vaccination). His exam noted enlarged erythematous swollen tonsils with exudate, mucoid nasal discharge, and expiratory wheezing that cleared with cough. He was diagnosed with bronchitis and treated with Z-PAK, albuterol inhaler, ENTEX PSE, and TYLENOL. There were no throat cultures obtained. He reported full recovery over next few weeks. On 4/7/2008, while deployed, he was examined for complaints of 2 week history of headaches, stuffed ears, sore throat, cough, sinus & chest congestion (symptom onset at 3/23/08 or 22 days after AVA vac #3). His exam was unremarkable with some clear nasal discharge and erythema cobblestone appearance to oral cavity. He was diagnosed and treated for sinusitis and URI with full recovery. Agency form on 8/15/2008 was marked yes for complaints of painful joints, back pain, heartburn and increased irritability. X-rays in Sept-Oct 2009 showed degenerative disc disease to L5-S1 and mild vacuum phenomena with spurring L5; and, DDD to C5-6 and C6-7 with straightening of cervical curvature. As of 2011 his diagnoses include hypertension, hypercholesterolemia, glucose intolerance, and he sees a chiropractor for episodic cervical, thoracic and lumbar spine somatic dysfunction (pain). He is currently preparing for a June 2011 deployment, is in smoking cessation program, voices no restrictions in daily activities, or an increase in seasonal URI like events pre-post vaccinations.